ETtech Exclusive: PharmEasy gets $300 million booster shot for Thyrocare deal
SECTIONS
Last Updated: Jun 28, 2021, 08:08 AM IST
Share
Synopsis
PharmEasy has raised $300 million more, bringing the total funding received by the online pharmacy since April to $650 million, most of which will be used to fund its ongoing acquisition of diagnostics chain Thyrocare.
ETtech
The Pharmeasy-Thyrocare deal will allow the online pharmacy to offer four key elements of healthcare information, consult, test and treatment at a time when online adoption is growing due to the pandemic. (Illustration: Rahul Awasthi/ETtech)
Bengaluru:PharmEasy has raised $300 million more, led by its existing investors, bringing the total funding received by the online pharmacy since April to $650 million, most of which will be used to fund its ongoing acquisition of diagnostic chain Thyrocare, a top executive told ET.
We take a closer look at the life of John McAfee, who was termed as the godfather of antivirus but was as far from the stereotype of a programmer as it s possible to be.